Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
P2X7/P2RX7 Antibody (Hano43), DyLight 650, Novus Biologicals™

Rat Monoclonal Antibody
Supplier: Novus Biologicals NBP140894C
Description
P2X7/P2RX7 Monoclonal specifically detects P2X7/P2RX7 in Mouse samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence.Specifications
P2X7/P2RX7 | |
Monoclonal | |
DyLight 650 | |
50 mM sodium borate with 0.05% sodium azide | |
P2RX7 | |
A P2X7-expression construct and a final boost with P2X7-transfected HEK cells. | |
0.1 mL | |
5027.0 | |
Mouse | |
IgG2b |
Flow Cytometry, Immunocytochemistry, Immunofluorescence | |
Hano43 | |
Flow Cytometry, Immunocytochemistry/Immunofluorescence | |
ATP receptor, MGC20089, P2X purinoceptor 7, P2X7P2X7 receptor, P2X7R, P2Z receptor, Purinergic receptor, purinergic receptor P2X, ligand-gated ion channel, 7, purinergic receptor P2X7 variant A | |
Rat | |
Protein G purified | |
Primary | |
This antibody recognises the P2X purinoceptor 7, also known as P2X7. The P2X7 ATP receptor has a distinctive long C-terminal tail with multiple potential protein and lipid interaction motifs and is highly polymorphic. It is a cation selective ion channel that opens up on binding of extracellular ATP. Sustained activation by extracellular ATP results in the formation of a reversible pore in the plasma membrane that is permeable to hydrophilic solutes of up to 900 Da. Once a pore is opened massive upset of cytoplasmic ion homeostasis occurs and the pore stays open as long as it is bound by ATP. Should ATP stimulation continue the cell will become irreversibly damaged and die. P2X7 plays a key role in the maturation and release of IL-1 and other IL-1 family members during inflammation. As such, P2X7 blockers might be useful as anti-inflammatory agents. | |
Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction